Resources | Oncofocus

Onco-Summaries: Daily Oncology Updates at a Glance

24/04/2025 Summary 1 (Ref 1): Akeso and Summit Therapeutics ' ivonescimab, a PD-1/VEGF bispecific antibody (BsAb), in combination with...

9 minutes ago2 min read

Dear Readers, Welcome to our inaugural CGT Watch newsletter! We’re excited to bring you monthly highlights on novel targets, innovative...

Mar 206 min read

“The right target, at the right time, for the right price” …is and always has been a guiding principle for Merck KGaA, as stated by its...

Feb 112 min read

The first-line metastatic Melanoma market is currently dominated by immune checkpoint inhibitors—BMS' Opdivo + Yervoy, Opdualag, Opdivo,...

Feb 73 min read

Bladder cancer is the most common malignancy of the urinary tract. As of 2022, Bladder Cancer had an incidence of 614,298 patients...

May 28, 20241 min read

Esophageal cancer is the fourteenth most commonly diagnosed cancer and the eighth leading cause of cancer-related death worldwide. The...

Apr 25, 20241 min read